Table 3.

Incidence, HR, 95% CI and p-value for outcome parameters in delayed versus early intervention with univariate analysis and adjusted for confounding factors

	Early intervention	Delayed intervention	HR	95% CI	p-value
All-cause mortality 30-day follow-up
Incidence (%)	1.3	1.4	1.07	0.49–2.35	0.86
– Adjusted for GRACE risk score			0.68	0.29–1.62	0.39
– Adjusted for serum creatinine, age, ST deviation and previous CABG			0.74	0.31–1.73	0.48
Reinfarction 30-day follow-up
Incidence (%)	0.8	0.8	1.02	0.37–2.81	0.97
– Adjusted for GRACE risk score			1.19	0.40–3.57	0.75
– Adjusted for diabetes, previous MI and age			0.66	0.23–1.88	0.44
Total bleeding events 30-day follow-up
Incidence (%)	18.2	16.7	0.89	0.71–1.11	0.28
– Adjusted for GRACE risk score			0.86	0.67–1.10	0.24
– Adjusted for age, ST deviation, previous CABG, max. CK			0.88	0.69–1.12	0.29
Non-CABG-related bleeding events 30-day follow-up
Incidence (%)	3.4	3.2	0.92	0.55–1.53	0.75
– Adjusted for GRACE risk score			0.73	0.41–1.27	0.26
– Adjusted for age, previous PCI and ST deviation			0.85	0.50–1.43	0.53
All-cause mortality 1‑year follow-up
Incidence (%)	4.1	7.0	1.67	1.12–2.49	0.01
– Adjusted for GRACE risk score			0.71	0.44–1.13	0.15
– Adjusted for age, diabetes, previous CABG			0.83	0.55–1.25	0.37

CABG coronary arterial bypass grafting, CI confidence interval, CK creatine kinase, GRACE Global Registry of Acute Coronary Syndromes, HR hazard ratio, MI myocardial infarction, PCI percutaneous coronary intervention